PellePharm to Highlight Clinical Programs at the 29th Congress of the European Academy of Dermatology and Venereology
Retrieved on:
Thursday, October 29, 2020
The presentations will be made during the 29th Congress of the European Academy of Dermatology and Venereology (EADV), to be held virtually October 29 31, 2020.
Key Points:
- The presentations will be made during the 29th Congress of the European Academy of Dermatology and Venereology (EADV), to be held virtually October 29 31, 2020.
- Our research continues to generate compelling evidence that supports patidegib as a clinical candidate and validates our approach in hedgehog inhibition.
- Details for the poster presentations at EADV Virtual are as follows:
We are encouraged by the continuing promise that patidegib is demonstrating in the clinic. - Patidegib topical gel has shown early promise in a Phase 2 clinical study for the mitigation of BCC tumors in Gorlin syndrome.